BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34394823)

  • 21. Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study.
    Rubino E; Boschi S; Giorgio E; Pozzi E; Marcinnò A; Gallo E; Roveta F; Grassini A; Brusco A; Rainero I
    Neurobiol Pain; 2022; 11():100089. PubMed ID: 35445161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.
    Xia S; Feng Z; Qi X; Yin Y; Jin J; Wu Y; Wu H; Feng Y; Tao M
    Med Oncol; 2015 Jan; 32(1):358. PubMed ID: 25428381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcript-dependent effects of the CALCA gene on the progression of post-traumatic osteoarthritis in mice.
    Jiang S; Xie W; Knapstein PR; Donat A; Albertsen LC; Sevecke J; Erdmann C; Appelt J; Fuchs M; Hildebrandt A; Maleitzke T; Frosch KH; Baranowsky A; Keller J
    Commun Biol; 2024 Feb; 7(1):223. PubMed ID: 38396204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-30a relieves migraine by degrading CALCA.
    Zhai Y; Zhu YY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2022-2028. PubMed ID: 29687858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of chloride intracellular channel 4 and Indian hedgehog proteins with survival of patients with pancreatic ductal adenocarcinoma.
    Zou Q; Yang Z; Li D; Liu Z; Yuan Y
    Int J Exp Pathol; 2016 Dec; 97(6):422-429. PubMed ID: 28205343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
    Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
    Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas.
    Semba S; Moriya T; Kimura W; Yamakawa M
    Pancreas; 2003 Apr; 26(3):250-7. PubMed ID: 12657951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.
    Camacho CP; Lindsey SC; Melo MC; Yang JH; Germano-Neto F; Valente Fde O; Lima TR; Biscolla RP; Vieira JG; Cerutti JM; Dias-da-Silva MR; Maciel RM
    Thyroid; 2013 Mar; 23(3):308-16. PubMed ID: 23259706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.
    Endo Y; Fujimoto M; Ito N; Takahashi Y; Kitago M; Gotoh M; Hiraoka N; Yoshida T; Kitagawa Y; Kanai Y; Arai E
    J Cancer Res Clin Oncol; 2021 May; 147(5):1341-1354. PubMed ID: 33635431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
    Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
    J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma.
    Zhang JF; Tao LY; Yang MW; Xu DP; Jiang SH; Fu XL; Liu DJ; Huo YM; Liu W; Yang JY; Hua R; Lu P; Sun YW
    Cancer Lett; 2021 Jun; 508():47-58. PubMed ID: 33766751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.
    Liu J; Cheng Sun SH; Sun SJ; Huang C; Hu HH; Jin YB; Qiu ZJ
    Ann Acad Med Singap; 2010 Jul; 39(7):548-7. PubMed ID: 20697673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
    Sarkar S; Mandal C; Sangwan R; Mandal C
    Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells.
    Smith AJ; Wen YA; Stevens PD; Liu J; Wang C; Gao T
    Oncotarget; 2016 Feb; 7(7):7801-15. PubMed ID: 26760962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.